In addition, Watanabe et al. [27] showed that the choline transporter CTL1 is highly expressed in tumour cells and that the inhibition of CTL1 function induces apoptotic cell death, making CTL1 a potential target in cancer therapy. The gene discussed is SLC44A1; the disease is neoplasm.